Red Pomegranate Peptides Show ACE and DPP-4 Inhibition Plus Antibacterial Activity
Peptides from red pomegranate protein hydrolysates showed triple functionality: antibacterial activity, ACE inhibition (blood pressure), and DPP-4 inhibition (blood sugar), demonstrating multi-target bioactive food peptides.
Quick Facts
What This Study Found
Red pomegranate protein hydrolysates demonstrated triple bioactivity: antibacterial, ACE-inhibitory, and DPP-4-inhibitory properties from food-derived peptides.
Key Numbers
Essential amino acids: ~23.3%. Hydrophobic amino acids: ~32.9%. Antioxidant amino acids: ~13.9%. PER index: ~2.1. Four enzymes tested.
How They Did This
Enzymatic hydrolysis of red pomegranate protein. Assessed antibacterial, ACE inhibitory, and DPP-4 inhibitory activities. Characterized nutritional value and bioactive peptide profiles.
Why This Research Matters
Finding a common food with peptides that simultaneously fight infections, lower blood pressure, and improve blood sugar control validates the concept of multi-target functional foods.
The Bigger Picture
Food-derived peptides with multiple health-promoting activities support the "food as medicine" concept. Pomegranate joins dairy, fish, and legumes as a source of multi-functional bioactive peptides.
What This Study Doesn't Tell Us
In vitro study. Bioactive peptide levels from dietary pomegranate consumption may be too low for therapeutic effects. Digestive stability needs confirmation.
Questions This Raises
- ?Could pomegranate protein supplements provide meaningful cardiometabolic benefits?
- ?Which specific pomegranate peptide sequences are most active?
- ?How do pomegranate peptides compare to dairy-derived bioactive peptides in potency?
Trust & Context
- Key Stat:
- Triple-action food peptides Pomegranate protein produces peptides that fight bacteria, lower blood pressure, and support blood sugar — three health benefits from one food
- Evidence Grade:
- Preliminary evidence: in vitro characterization of pomegranate protein bioactive peptide activities.
- Study Age:
- Published in 2025. Expands pomegranate health science beyond antioxidants to bioactive peptides.
- Original Title:
- Nutritional value, antibacterial activity, ACE and DPP IV inhibitory of red pomegranate seeds protein and peptides.
- Published In:
- Scientific reports, 15(1), 10802 (2025)
- Authors:
- Akbarbaglu, Zahra, Mazloomi, Narges(2), Karimzadeh, Laleh(2), Sarabandi, Khashayar, Jafari, Seid Mahdi, Hesarinejad, Mohammad Ali
- Database ID:
- RPEP-09810
Evidence Hierarchy
Frequently Asked Questions
Is pomegranate good for blood pressure and blood sugar?
This study found pomegranate proteins release peptides that inhibit both ACE (blood pressure enzyme) and DPP-4 (preserves GLP-1 for blood sugar). While the effect from dietary consumption is mild compared to drugs, pomegranate adds multi-target health support to your diet.
How do I get these pomegranate peptides?
Your body naturally releases these peptides when you digest pomegranate protein. Eating whole pomegranate (including seeds) provides the protein source. Pomegranate juice has less protein but more antioxidants. Future supplements could concentrate the bioactive peptides.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09810APA
Akbarbaglu, Zahra; Mazloomi, Narges; Karimzadeh, Laleh; Sarabandi, Khashayar; Jafari, Seid Mahdi; Hesarinejad, Mohammad Ali. (2025). Nutritional value, antibacterial activity, ACE and DPP IV inhibitory of red pomegranate seeds protein and peptides.. Scientific reports, 15(1), 10802. https://doi.org/10.1038/s41598-025-95089-5
MLA
Akbarbaglu, Zahra, et al. "Nutritional value, antibacterial activity, ACE and DPP IV inhibitory of red pomegranate seeds protein and peptides.." Scientific reports, 2025. https://doi.org/10.1038/s41598-025-95089-5
RethinkPeptides
RethinkPeptides Research Database. "Nutritional value, antibacterial activity, ACE and DPP IV in..." RPEP-09810. Retrieved from https://rethinkpeptides.com/research/akbarbaglu-2025-nutritional-value-antibacterial-activity
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.